Innovative Companies Diving into The Neuro Market Ahead of 2021
The Pharma Data
DECEMBER 9, 2020
Atlas cofounded, seeded and incubated Vigil, with pre-clinical stage assets in-licensed from Amgen Inc., The company plans to do this by developing drugs that eliminate protein aggregation by either reducing the production of toxic proteins or removing them after the fact through autophagy. which will remain a key shareholder.
52 
Let's personalize your content